Latest On Aimmune Therapeutics, Inc (AIMT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-11-01 16:54 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-10-15 19:30 EST | Insider Trade | des Produits Nestle S.A. Societe has indirectly acquired of 10,681,704 shares. | Buy | |
| 2020-10-15 19:30 EST | Insider Trade | des Produits Nestle S.A. Societe has indirectly acquired of 43,435,583 shares. | Buy | |
| 2020-10-15 08:03 EST | Analyst Rating | The Analyst Target Price has decreased from $33.32 to $31.28. | Sell | |
| 2020-10-14 16:31 EST | Insider Trade | KATHRYN E FALBERG has directly disposed of 7,840 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:31 EST | Insider Trade | DANIEL C MD ADELMAN has directly disposed of 22,343 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:31 EST | Insider Trade | Mark T Iwicki has directly disposed of 7,840 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:31 EST | Insider Trade | PATRICK G ENRIGHT has directly disposed of 7,840 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:31 EST | Insider Trade | ERIC BJERKHOLT has directly disposed of 23,905 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:30 EST | Insider Trade | Stacey Denenberg Seltzer has directly disposed of 7,840 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:30 EST | Insider Trade | BRETT K HAUMANN has directly disposed of 13,313 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:30 EST | Insider Trade | Gregory Behar has directly disposed of 7,840 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:30 EST | Insider Trade | MARK MCDADE has directly disposed of 7,840 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:30 EST | Insider Trade | Jayson Donald Alexander Dallas has directly disposed of 89,250 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:30 EST | Insider Trade | Douglas T. Sheehy has directly disposed of 36,875 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 16:30 EST | Insider Trade | Andrew Oxtoby has directly disposed of 20,250 shares and currently holds 0 shares. | Sell | |
| 2020-10-14 05:41 EST | News | Nestle reports 84% holding in Aimmune Therapeutics | N/A | |
| 2020-10-05 22:00 EST | Insider Trade | DANIEL C MD ADELMAN has directly acquired 34,932 shares and currently holds 63,807 shares. | Buy | |
| 2020-10-05 21:15 EST | Insider Trade | ERIC BJERKHOLT has directly acquired 5,200 shares and currently holds 49,841 shares. | Buy | |
| 2020-10-05 21:15 EST | Insider Trade | Douglas T. Sheehy has directly acquired 30,888 shares and currently holds 85,426 shares. | Buy | |
| 2020-09-26 04:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-21 13:34 EST | News | Nestle Acquiring Aimmune, And Other News: The Good, Bad And Ugly Of Biopharma | N/A | |
| 2020-09-21 13:33 EST | News | Aimmune Therapeutics: Do Not Tender Your Shares To Nestle | N/A | |
| 2020-09-14 08:03 EST | Analyst Rating | The Analyst Target Price has increased from $32.77 to $33.32. | Neutral | |
| 2020-09-14 03:31 EST | News | Nestle initiates tender offer for Aimmune Therapeutics | N/A | |
| 2020-09-10 17:29 EST | News | Aimmune Therapeutics: A Bargain For A Potential Blockbuster Therapy | N/A | |
| 2020-09-01 12:03 EST | Analyst Rating | The Analyst Target Price has decreased from $35.18 to $32.77. | Sell | |
| 2020-09-01 01:37 EST | News | Nestle to buy Aimmune Therapeutics for $2.6B | N/A | |
| 2020-08-05 06:51 EST | News | DBV Technologies down big on FDA rejection of Viaskin Peanut application | N/A | |
| 2020-08-03 08:04 EST | Analyst Rating | The Analyst Target Price has decreased from $38.36 to $35.18. | Neutral | |
| 2020-08-03 00:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-02 00:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 16:50 EST | News | Aimmune Therapeutics EPS beats by $0.03 | N/A | |
| 2020-07-31 16:49 EST | News | Aimmune Therapeutics, Inc. (AIMT) CEO Jayson Dallas on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-07-31 00:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 00:05 EST | Analyst Rating | The Analyst Target Price has decreased from $38.73 to $38.36. | Neutral | |
| 2020-07-30 15:09 EST | News | Aimmune Therapeutics Q2 Earnings Preview | N/A | |
| 2020-07-29 08:03 EST | Analyst Rating | The Analyst Target Price has increased from $38.64 to $38.73. | Buy | |
| 2020-07-28 15:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-24 00:04 EST | Analyst Rating | The Analyst Target Price has decreased from $38.82 to $38.64. | Neutral | |
| 2020-07-23 16:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-20 08:03 EST | Analyst Rating | The Analyst Target Price has decreased from $39.2 to $38.82. | Neutral | |
| 2020-06-09 08:03 EST | Analyst Rating | The Analyst Target Price has increased from $36.89 to $39.2. | Buy | |
| 2020-06-08 12:13 EST | News | Aimmune's Palforzia shows durable effect in study | N/A | |
| 2020-06-02 08:03 EST | Earnings Estimate | An EPS average of -$1.03 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-06-02 08:03 EST | Analyst Rating | The Analyst Target Price has decreased from $43.1 to $36.89. | Neutral | |
| 2020-05-29 19:30 EST | Insider Trade | Stacey Denenberg Seltzer has directly acquired 7,840 shares and currently holds 18,061 shares. | Buy | |
| 2020-05-29 19:30 EST | Insider Trade | MARK MCDADE has directly acquired 7,840 shares and currently holds 34,692 shares. | Buy | |
| 2020-05-29 19:30 EST | Insider Trade | PATRICK G ENRIGHT has directly disposed of 7,840 shares and currently holds 78,401 shares. | Sell | |
| 2020-05-29 19:30 EST | Insider Trade | KATHRYN E FALBERG has directly acquired 7,840 shares and currently holds 73,032 shares. | Buy | |
About Aimmune Therapeutics, Inc (AIMT):
Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Its lead Characterized Oral Desensitization ImmunoTherapy (CODIT) product candidate is AR101, an investigational biologic, which is in Phase III clinical trial for the treatment of patients with peanut allergy. The company also engages in the research and development of AR201, a CODIT product candidate for the treatment of egg allergy in pediatric and young adult patients; and other CODIT product candidates targeting food allergies, such as cow's milk allergy. Aimmune Therapeutics, Inc. has a strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics; and clinical collaboration agreement with Regeneron Ireland Unlimited Company and Sanofi Biotechnology SAS to study AR101 with adjunctive dupilumab in peanut-allergic patients in a Phase II trial. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015. Aimmune Therapeutics, Inc. was founded in 2011 and is headquartered in Brisbane, California. As of October 9, 2020, Aimmune Therapeutics, Inc. operates as a subsidiary of Société des Produits Nestlé S.A.
General
- Name Aimmune Therapeutics, Inc
- Symbol AIMT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 339
- Fiscal Year EndDecember
- IPO Date2015-08-06
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.aimmune.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 3832.47
- Price/Book (Most Recent Quarter) 12.55
- Enterprise Value Revenue 3628.88
View More
Financials
- Most Recent Quarter 2020-06-30
- Next Quarter EPS Estimate -$1.05
- Operating Margin -49193%
- Return on Assets -53%
- Revenue 575000
- Earnings Per Share -$3.73
- Revenue Per Share $0.01
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 2.26 billion
- EBITDA -227014000
- PEG Ratio 0.16
- Analyst Target Price $31.28
- Book Value Per Share $2.75
View More
Share Statistics
- Shares Outstanding 65.45 million
- Shares Float 49.01 million
- % Held by Insiders 2086%
- % Held by Institutions 82.85%
- Shares Short 4.18 million
- Shares Short Prior Month 6.74 million
- Short Ratio 0.99
- Short % of Float 9%
- Short % of Shares Outstanding 6%
View More
Technicals
- Beta 1.74
- 52 Week High $37
- 52 Week Low $10.09
- 50 Day Moving Average 34.42
- 200 Day Moving Average 20.82
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Aimmune Therapeutics, Inc (AIMT) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Aimmune Therapeutics, Inc (AIMT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-06-30 | 2020-07-30 | $N/A | -$1.06 | -$1.09 | 2.75% |
| 2020-03-31 | 2020-05-11 | $575000 | -$1.34 | -$1.18 | -13.56% |
| 2019-12-31 | 2020-02-27 | $N/A | -$1.06 | -$1.06 | 0% |
| 2019-09-30 | 2019-11-06 | $N/A | -$1.03 | -$1.03 | 0% |
| 2019-06-30 | 2019-08-08 | $N/A | -$1.01 | -$0.94 | -7.45% |
| 2019-03-31 | 2019-05-08 | $N/A | -$0.87 | -$0.97 | 10.31% |
| 2018-12-31 | 2019-02-28 | $N/A | -$0.95 | -$0.91 | -4.4% |
| 2018-09-30 | 2018-11-08 | $N/A | -$0.89 | -$0.90 | 1.11% |
| 2018-06-30 | 2018-08-08 | $N/A | -$0.91 | -$0.86 | -5.81% |
| 2018-03-31 | 2018-05-08 | $N/A | -$0.92 | -$0.71 | -29.58% |
| 2017-12-31 | 2018-02-20 | $N/A | -$0.81 | -$0.73 | -10.96% |
| 2017-09-30 | 2017-11-06 | $N/A | -$0.63 | -$0.72 | 12.5% |
| 2017-06-30 | 2017-08-08 | $N/A | -$0.65 | -$0.64 | -1.56% |
| 2017-03-31 | 2017-05-08 | $N/A | -$0.52 | -$0.56 | 7.14% |
| 2016-12-31 | 2017-03-15 | $N/A | -$0.55 | -$0.47 | -17.02% |
| 2016-09-30 | 2016-11-14 | $N/A | -$0.53 | -$0.46 | -15.22% |
| 2016-06-30 | 2016-08-10 | $N/A | -$0.43 | -$0.41 | -4.88% |
| 2016-03-31 | 2016-05-16 | $N/A | -$0.37 | -$0.40 | 7.5% |
| 2015-12-31 | 2016-03-03 | $N/A | -$0.39 | -$0.35 | -11.43% |
| 2015-09-30 | 2015-11-04 | $N/A | -$0.36 | -$0.23 | -56.52% |
| 2015-06-30 | 2015-08-06 | $N/A | -$1.60 | -$0.28 | -471.43% |
Aimmune Therapeutics, Inc (AIMT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Aimmune Therapeutics, Inc (AIMT) Chart:
Aimmune Therapeutics, Inc (AIMT) News:
Below you will find a list of latest news for Aimmune Therapeutics, Inc (AIMT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Aimmune Therapeutics, Inc (AIMT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Aimmune Therapeutics, Inc (AIMT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320017779/0000899243-20-017779-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000008025519002707/0000080255-19-002707-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000008025520001302/0000080255-20-001302-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000021545719003094/0000215457-19-003094-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000031506619000828/0000315066-19-000828-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000083423720004580/0000834237-20-004580-index.htm |
| 2018-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318006569/0000899243-18-006569-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013923/0000899243-18-013923-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013924/0000899243-18-013924-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013926/0000899243-18-013926-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013930/0000899243-18-013930-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013931/0000899243-18-013931-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013932/0000899243-18-013932-index.htm |
| 2018-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013933/0000899243-18-013933-index.htm |
| 2018-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2018-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm |
| 2018-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318016350/0000899243-18-016350-index.htm |
| 2018-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318016599/0000899243-18-016599-index.htm |
| 2018-06-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318017242/0000899243-18-017242-index.htm |
| 2018-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318017243/0000899243-18-017243-index.htm |
| 2018-11-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318028402/0000899243-18-028402-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318029386/0000899243-18-029386-index.htm |
| 2018-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924318029542/0000899243-18-029542-index.htm |
| 2019-01-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319001868/0000899243-19-001868-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319001869/0000899243-19-001869-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004861/0000899243-19-004861-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004862/0000899243-19-004862-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004863/0000899243-19-004863-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004864/0000899243-19-004864-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004866/0000899243-19-004866-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014962/0000899243-19-014962-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014964/0000899243-19-014964-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014965/0000899243-19-014965-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014969/0000899243-19-014969-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014970/0000899243-19-014970-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014971/0000899243-19-014971-index.htm |
| 2019-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319023912/0000899243-19-023912-index.htm |
| 2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319023984/0000899243-19-023984-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319028948/0000899243-19-028948-index.htm |
| 2019-12-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924319030174/0000899243-19-030174-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320000395/0000899243-20-000395-index.htm |
| 2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320001533/0000899243-20-001533-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320004692/0000899243-20-004692-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320004693/0000899243-20-004693-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320004694/0000899243-20-004694-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320004697/0000899243-20-004697-index.htm |
| 2020-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320004699/0000899243-20-004699-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006843/0000899243-20-006843-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006850/0000899243-20-006850-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006851/0000899243-20-006851-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006852/0000899243-20-006852-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006853/0000899243-20-006853-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007093/0000899243-20-007093-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007096/0000899243-20-007096-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007098/0000899243-20-007098-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007103/0000899243-20-007103-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007110/0000899243-20-007110-index.htm |
| 2020-03-04 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007111/0000899243-20-007111-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007813/0000899243-20-007813-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007815/0000899243-20-007815-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320008140/0000899243-20-008140-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320008621/0000899243-20-008621-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320009016/0000899243-20-009016-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320011292/0000899243-20-011292-index.htm |
| 2020-04-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320011293/0000899243-20-011293-index.htm |
| 2020-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320011298/0000899243-20-011298-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012850/0000899243-20-012850-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012853/0000899243-20-012853-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012855/0000899243-20-012855-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012859/0000899243-20-012859-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012860/0000899243-20-012860-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014609/0000899243-20-014609-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014611/0000899243-20-014611-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014612/0000899243-20-014612-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014615/0000899243-20-014615-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014618/0000899243-20-014618-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014619/0000899243-20-014619-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014621/0000899243-20-014621-index.htm |
| 2020-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320017779/0000899243-20-017779-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320025342/0000899243-20-025342-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320025345/0000899243-20-025345-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320025348/0000899243-20-025348-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320025349/0000899243-20-025349-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320025350/0000899243-20-025350-index.htm |
| 2020-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320026210/0000899243-20-026210-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320027457/0000899243-20-027457-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320027458/0000899243-20-027458-index.htm |
| 2020-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320027460/0000899243-20-027460-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028171/0000899243-20-028171-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028172/0000899243-20-028172-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028173/0000899243-20-028173-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028174/0000899243-20-028174-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028176/0000899243-20-028176-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/0000899243-20-028177-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028178/0000899243-20-028178-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/0000899243-20-028179-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028180/0000899243-20-028180-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028181/0000899243-20-028181-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028182/0000899243-20-028182-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028183/0000899243-20-028183-index.htm |
| 2020-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028359/0000899243-20-028359-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000093247119004464/0000932471-19-004464-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000110465920018693/0001104659-20-018693-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000110465920020466/0001104659-20-020466-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000114420419007017/0001144204-19-007017-index.htm |
| 2018-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312518189409/0001193125-18-189409-index.htm |
| 2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312518324626/0001193125-18-324626-index.htm |
| 2018-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312518329424/0001193125-18-329424-index.htm |
| 2018-11-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312518336579/0001193125-18-336579-index.htm |
| 2018-12-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1631650/000119312518340885/0001193125-18-340885-index.htm |
| 2019-01-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519000571/0001193125-19-000571-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519002500/0001193125-19-002500-index.htm |
| 2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519008957/0001193125-19-008957-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000119312519036136/0001193125-19-036136-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519077540/0001193125-19-077540-index.htm |
| 2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519084341/0001193125-19-084341-index.htm |
| 2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519146671/0001193125-19-146671-index.htm |
| 2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519175698/0001193125-19-175698-index.htm |
| 2019-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519245134/0001193125-19-245134-index.htm |
| 2019-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519293433/0001193125-19-293433-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312519320879/0001193125-19-320879-index.htm |
| 2020-01-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312520021708/0001193125-20-021708-index.htm |
| 2020-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312520024920/0001193125-20-024920-index.htm |
| 2020-02-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1631650/000119312520030952/0001193125-20-030952-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000119312520033257/0001193125-20-033257-index.htm |
| 2020-04-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1631650/000119312520119135/0001193125-20-119135-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312520235288/0001193125-20-235288-index.htm |
| 2020-08-31 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1631650/000119312520235338/0001193125-20-235338-index.htm |
| 2020-08-31 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/1631650/000119312520235341/0001193125-20-235341-index.htm |
| 2020-08-31 | SC14D9C | Written communication relating to third party tender offer | https://www.sec.gov/Archives/edgar/data/1631650/000119312520236371/0001193125-20-236371-index.htm |
| 2020-09-14 | SC TO-C | Written communication relating to an issuer or third party | https://www.sec.gov/Archives/edgar/data/1631650/000119312520244703/0001193125-20-244703-index.htm |
| 2020-09-14 | SC 13E3 | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1631650/000119312520245300/0001193125-20-245300-index.htm |
| 2020-09-14 | SC 14D9 | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1631650/000119312520245325/0001193125-20-245325-index.htm |
| 2020-09-14 | SC 13E3 | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1631650/000119312520245328/0001193125-20-245328-index.htm |
| 2020-09-21 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1631650/000119312520249713/0001193125-20-249713-index.htm |
| 2020-09-21 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1631650/000119312520249724/0001193125-20-249724-index.htm |
| 2020-09-21 | SC 13E3/A | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1631650/000119312520249725/0001193125-20-249725-index.htm |
| 2020-09-24 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1631650/000119312520253505/0001193125-20-253505-index.htm |
| 2020-09-29 | SC 13E3/A | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1631650/000119312520257100/0001193125-20-257100-index.htm |
| 2020-09-29 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1631650/000119312520257119/0001193125-20-257119-index.htm |
| 2020-09-29 | SC 13E3/A | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1631650/000119312520257121/0001193125-20-257121-index.htm |
| 2020-10-02 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1631650/000119312520262502/0001193125-20-262502-index.htm |
| 2020-10-05 | SC 13E3/A | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1631650/000119312520263192/0001193125-20-263192-index.htm |
| 2020-10-05 | SC TO-T/A | Tender offer statement by Third Party | https://www.sec.gov/Archives/edgar/data/1631650/000119312520264012/0001193125-20-264012-index.htm |
| 2020-10-05 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1631650/000119312520264022/0001193125-20-264022-index.htm |
| 2020-10-08 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1631650/000119312520266415/0001193125-20-266415-index.htm |
| 2020-10-13 | SC 13E3/A | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268115/0001193125-20-268115-index.htm |
| 2020-10-13 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268119/0001193125-20-268119-index.htm |
| 2020-10-13 | SC 14D9/A | Solicitation, recommendation statements | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268136/0001193125-20-268136-index.htm |
| 2020-10-13 | SC 13E3/A | Going private transaction by certain issuers | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268141/0001193125-20-268141-index.htm |
| 2020-10-13 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268640/0001193125-20-268640-index.htm |
| 2020-10-13 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268641/0001193125-20-268641-index.htm |
| 2020-10-13 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268643/0001193125-20-268643-index.htm |
| 2020-10-13 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268644/0001193125-20-268644-index.htm |
| 2020-10-13 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268646/0001193125-20-268646-index.htm |
| 2020-10-13 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268648/0001193125-20-268648-index.htm |
| 2020-10-13 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268649/0001193125-20-268649-index.htm |
| 2020-10-13 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1631650/000119312520268654/0001193125-20-268654-index.htm |
| 2020-10-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000119312520272122/0001193125-20-272122-index.htm |
| 2020-10-23 | 15-12B | Securities registration termination [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1631650/000119312520275192/0001193125-20-275192-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1631650/000130692320000004/0001306923-20-000004-index.htm |
| 2020-10-13 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/1631650/000135445720000580/0001354457-20-000580-index.htm |
| 2018-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459018005311/0001564590-18-005311-index.htm |
| 2018-04-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1631650/000156459018007999/0001564590-18-007999-index.htm |
| 2018-04-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1631650/000156459018008002/0001564590-18-008002-index.htm |
| 2018-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459018011815/0001564590-18-011815-index.htm |
| 2018-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631650/000156459018011827/0001564590-18-011827-index.htm |
| 2018-05-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459018014374/0001564590-18-014374-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459018020500/0001564590-18-020500-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631650/000156459018020513/0001564590-18-020513-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459018027504/0001564590-18-027504-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459018028558/0001564590-18-028558-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631650/000156459018028572/0001564590-18-028572-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459019005464/0001564590-19-005464-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1631650/000156459019005514/0001564590-19-005514-index.htm |
| 2019-02-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1631650/000156459019005544/0001564590-19-005544-index.htm |
| 2019-04-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1631650/000156459019011278/0001564590-19-011278-index.htm |
| 2019-04-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1631650/000156459019011280/0001564590-19-011280-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459019017185/0001564590-19-017185-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631650/000156459019017202/0001564590-19-017202-index.htm |
| 2019-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459019020915/0001564590-19-020915-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459019030768/0001564590-19-030768-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631650/000156459019030786/0001564590-19-030786-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459019041020/0001564590-19-041020-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631650/000156459019041059/0001564590-19-041059-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459020007372/0001564590-20-007372-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1631650/000156459020007384/0001564590-20-007384-index.htm |
| 2020-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1631650/000156459020007397/0001564590-20-007397-index.htm |
| 2020-04-09 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1631650/000156459020016143/0001564590-20-016143-index.htm |
| 2020-04-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1631650/000156459020016146/0001564590-20-016146-index.htm |
| 2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459020024181/0001564590-20-024181-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631650/000156459020024196/0001564590-20-024196-index.htm |
| 2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459020027348/0001564590-20-027348-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1631650/000156459020034776/0001564590-20-034776-index.htm |
| 2020-07-31 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1631650/000156459020034973/0001564590-20-034973-index.htm |
| 2018-11-29 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1631650/000163165018000003/0001631650-18-000003-index.htm |
| 2018-03-16 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1631650/000164892018000001/0001648920-18-000001-index.htm |
| 2020-10-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1631650/999999999520002834/9999999995-20-002834-index.htm |
| 2020-10-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1631650/999999999520002835/9999999995-20-002835-index.htm |
| 2018-03-27 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1631650/999999999718003873/9999999997-18-003873-index.htm |
| 2018-08-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1631650/999999999718007153/9999999997-18-007153-index.htm |
| 2018-12-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1631650/999999999718009615/9999999997-18-009615-index.htm |
| 2019-03-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1631650/999999999719001550/9999999997-19-001550-index.htm |
Aimmune Therapeutics, Inc (AIMT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aimmune Therapeutics, Inc (AIMT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2086%Institutional Ownership: 8285%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-10-13 | Andrew Oxtoby | Chief Commercial Officer | Sell | 20,250.00 | 34.50 | 698,625.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028183/0000899243-20-028183-index.htm |
| 2020-10-13 | BRETT K HAUMANN | Director | Sell | 13,313.00 | 34.50 | 459,298.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028178/0000899243-20-028178-index.htm |
| 2020-10-13 | DANIEL C MD ADELMAN | Chief Medical Officer | Sell | 22,343.00 | 34.50 | 770,833.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028171/0000899243-20-028171-index.htm |
| 2020-10-13 | Douglas T. Sheehy | Officer | Sell | 36,875.00 | 34.50 | 1,272,187.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028182/0000899243-20-028182-index.htm |
| 2020-10-13 | ERIC BJERKHOLT | Chief Financial Officer | Sell | 23,905.00 | 34.50 | 824,722.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028176/0000899243-20-028176-index.htm |
| 2020-10-13 | Gregory Behar | Director | Sell | 7,840.00 | 34.50 | 270,480.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028179/0000899243-20-028179-index.htm |
| 2020-10-13 | Jayson Donald Alexander Dallas | President and CEO | Sell | 89,250.00 | 34.50 | 3,079,125.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028181/0000899243-20-028181-index.htm |
| 2020-10-13 | KATHRYN E FALBERG | Director | Sell | 7,840.00 | 34.50 | 270,480.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028172/0000899243-20-028172-index.htm |
| 2020-10-13 | MARK MCDADE | Director | Sell | 7,840.00 | 34.50 | 270,480.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028180/0000899243-20-028180-index.htm |
| 2020-10-13 | Mark T Iwicki | Director | Sell | 7,840.00 | 34.50 | 270,480.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028174/0000899243-20-028174-index.htm |
| 2020-10-13 | PATRICK G ENRIGHT | Director | Sell | 7,840.00 | 34.50 | 270,480.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028173/0000899243-20-028173-index.htm |
| 2020-10-13 | Stacey Denenberg Seltzer | Director | Sell | 7,840.00 | 34.50 | 270,480.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028177/0000899243-20-028177-index.htm |
| 2019-05-23 | Gregory Behar | Director | Buy | 6,442.00 | 10,192.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014971/0000899243-19-014971-index.htm | ||
| 2019-05-23 | Stacey Denenberg Seltzer | Director | Buy | 6,442.00 | 10,221.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014965/0000899243-19-014965-index.htm | ||
| 2018-11-28 | Nestle Health Science US Holdings, Inc. | 10% Share Holder | Buy | 3,237,529.00 | 30.27 | 98,000,002.83 | 11,727,113.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320011292/0000899243-20-011292-index.htm |
| 2019-01-22 | Andrew Oxtoby | Chief Commercial Officer | Buy | 12,000.00 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319001869/0000899243-19-001869-index.htm | ||
| 2020-03-10 | Jayson Donald Alexander Dallas | President and CEO | Buy | 2,665.00 | 18.74 | 49,934.11 | 123,283.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007815/0000899243-20-007815-index.htm |
| 2020-02-28 | Jayson Donald Alexander Dallas | President and CEO | Buy | 33,000.00 | 123,699.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006853/0000899243-20-006853-index.htm | ||
| 2020-05-10 | Jayson Donald Alexander Dallas | President and CEO | Buy | 3,300.00 | 126,583.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012860/0000899243-20-012860-index.htm | ||
| 2020-02-07 | des Produits Nestle S.A. Societe | 10% Share Holder | Buy | 1,000,000.00 | 31.97 | 31,970,000.00 | 12,727,113.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320011298/0000899243-20-011298-index.htm |
| 2018-05-23 | KATHRYN E FALBERG | Director | Buy | 3,750.00 | 128,644.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013924/0000899243-18-013924-index.htm | ||
| 2019-02-22 | Mary M. Rozenman | Officer | Buy | 7,500.00 | 14,504.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004862/0000899243-19-004862-index.htm | ||
| 2020-05-27 | Gregory Behar | Director | Buy | 7,840.00 | 18,032.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014619/0000899243-20-014619-index.htm | ||
| 2020-05-27 | Stacey Denenberg Seltzer | Director | Buy | 7,840.00 | 18,061.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014609/0000899243-20-014609-index.htm | ||
| 2018-06-13 | ERIC BJERKHOLT | Chief Financial Officer | Buy | 1,600.00 | 30.41 | 48,663.04 | 19,485.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318016599/0000899243-18-016599-index.htm |
| 2020-05-27 | BRETT K HAUMANN | Director | Buy | 13,313.00 | 19,563.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014618/0000899243-20-014618-index.htm | ||
| 2018-05-23 | MARK MCDADE | Director | Buy | 3,750.00 | 20,410.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013923/0000899243-18-013923-index.htm | ||
| 2019-02-22 | DANIEL C MD ADELMAN | Chief Medical Officer | Buy | 11,875.00 | 21,250.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004864/0000899243-19-004864-index.htm | ||
| 2019-12-09 | DANIEL C MD ADELMAN | Chief Medical Officer | Sell | 20,000.00 | 30.04 | 600,716.00 | 21,250.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319028948/0000899243-19-028948-index.htm |
| 2020-01-02 | DANIEL C MD ADELMAN | Chief Medical Officer | Sell | 20,000.00 | 35.00 | 700,038.00 | 21,250.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320000395/0000899243-20-000395-index.htm |
| 2020-02-28 | Andrew Oxtoby | Chief Commercial Officer | Buy | 11,250.00 | 23,250.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006850/0000899243-20-006850-index.htm | ||
| 2020-10-13 | des Produits Nestle S.A. Societe | 10% Share Holder | Buy | 10,681,704.00 | 34.50 | 368,518,788.00 | 23,408,817.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028359/0000899243-20-028359-index.htm |
| 2020-03-13 | Andrew Oxtoby | Chief Commercial Officer | Buy | 3,000.00 | 14.76 | 44,265.90 | 25,015.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320008621/0000899243-20-008621-index.htm |
| 2018-05-23 | PATRICK G ENRIGHT | Director | Buy | 3,750.00 | 26,619.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013933/0000899243-18-013933-index.htm | ||
| 2019-05-23 | MARK MCDADE | Director | Buy | 6,442.00 | 26,852.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014970/0000899243-19-014970-index.htm | ||
| 2020-05-10 | Andrew Oxtoby | Chief Commercial Officer | Buy | 2,420.00 | 27,435.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012853/0000899243-20-012853-index.htm | ||
| 2020-02-28 | DANIEL C MD ADELMAN | Chief Medical Officer | Buy | 8,750.00 | 29,167.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006851/0000899243-20-006851-index.htm | ||
| 2020-05-10 | DANIEL C MD ADELMAN | Chief Medical Officer | Buy | 2,420.00 | 29,715.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012850/0000899243-20-012850-index.htm | ||
| 2018-06-01 | STEPHEN GEORGE DILLY | Officer | Sell | 2,498.00 | 33.19 | 82,898.63 | 315,308.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2018-06-04 | STEPHEN GEORGE DILLY | Officer | Sell | 2,612.00 | 32.74 | 85,519.49 | 315,308.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2018-06-05 | STEPHEN GEORGE DILLY | Officer | Sell | 38,825.00 | 31.83 | 1,235,834.69 | 315,308.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2018-06-06 | STEPHEN GEORGE DILLY | President and CEO | Sell | 30,465.00 | 31.20 | 950,370.91 | 315,308.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm |
| 2018-06-07 | STEPHEN GEORGE DILLY | President and CEO | Sell | 500.00 | 31.58 | 15,790.00 | 315,308.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm |
| 2018-06-08 | STEPHEN GEORGE DILLY | President and CEO | Sell | 42,106.00 | 30.70 | 1,292,511.04 | 315,308.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm |
| 2018-06-11 | STEPHEN GEORGE DILLY | President and CEO | Sell | 29,457.00 | 30.83 | 908,300.70 | 315,308.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318016350/0000899243-18-016350-index.htm |
| 2018-06-07 | STEPHEN GEORGE DILLY | President and CEO | Sell | 32,098.00 | 30.95 | 993,320.76 | 315,808.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm |
| 2018-06-01 | STEPHEN GEORGE DILLY | Officer | Sell | 58,699.00 | 32.59 | 1,913,094.33 | 317,806.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2018-06-04 | STEPHEN GEORGE DILLY | Officer | Sell | 62,740.00 | 31.84 | 1,997,836.09 | 317,920.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2019-02-22 | ERIC BJERKHOLT | Chief Financial Officer | Buy | 13,125.00 | 32,857.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004863/0000899243-19-004863-index.htm | ||
| 2019-05-23 | PATRICK G ENRIGHT | Director | Buy | 6,442.00 | 33,061.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014964/0000899243-19-014964-index.htm | ||
| 2018-05-22 | Douglas T. Sheehy | Officer | Sell | 1,648.00 | 33.00 | 54,384.00 | 33,079.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013932/0000899243-18-013932-index.htm |
| 2018-05-23 | Mark T Iwicki | Director | Buy | 3,750.00 | 33,125.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013926/0000899243-18-013926-index.htm | ||
| 2019-09-18 | ERIC BJERKHOLT | Chief Financial Officer | Buy | 1,550.00 | 22.57 | 34,976.68 | 33,574.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319023984/0000899243-19-023984-index.htm |
| 2018-06-11 | STEPHEN GEORGE DILLY | President and CEO | Buy | 29,457.00 | 3.02 | 89,022.00 | 344,765.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318016350/0000899243-18-016350-index.htm |
| 2018-06-06 | STEPHEN GEORGE DILLY | President and CEO | Buy | 30,465.00 | 3.02 | 92,068.28 | 345,773.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm |
| 2020-05-27 | MARK MCDADE | Director | Buy | 7,840.00 | 34,692.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014611/0000899243-20-014611-index.htm | ||
| 2018-05-22 | Douglas T. Sheehy | Officer | Buy | 1,648.00 | 12.95 | 21,341.60 | 34,727.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013932/0000899243-18-013932-index.htm |
| 2018-06-07 | STEPHEN GEORGE DILLY | President and CEO | Buy | 32,598.00 | 3.02 | 98,514.42 | 347,906.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm |
| 2018-06-05 | STEPHEN GEORGE DILLY | Officer | Buy | 38,825.00 | 3.02 | 117,333.03 | 354,133.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2018-06-08 | STEPHEN GEORGE DILLY | President and CEO | Buy | 42,106.00 | 3.02 | 127,248.54 | 357,414.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015796/0000899243-18-015796-index.htm |
| 2018-05-23 | Gregory Behar | Director | Buy | 3,750.00 | 3,750.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013930/0000899243-18-013930-index.htm | ||
| 2018-06-01 | STEPHEN GEORGE DILLY | Officer | Buy | 61,197.00 | 3.02 | 184,943.45 | 376,505.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2018-05-23 | Stacey Denenberg Seltzer | Director | Buy | 3,750.00 | 3,779.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318013931/0000899243-18-013931-index.htm | ||
| 2018-06-04 | STEPHEN GEORGE DILLY | Officer | Buy | 65,352.00 | 3.02 | 197,500.28 | 380,660.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318015156/0000899243-18-015156-index.htm |
| 2019-05-23 | Mark T Iwicki | Director | Buy | 6,442.00 | 39,567.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014962/0000899243-19-014962-index.htm | ||
| 2019-12-09 | DANIEL C MD ADELMAN | Chief Medical Officer | Buy | 20,000.00 | 11.45 | 229,000.00 | 41,250.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319028948/0000899243-19-028948-index.htm |
| 2020-01-02 | DANIEL C MD ADELMAN | Chief Medical Officer | Buy | 20,000.00 | 19.63 | 392,600.00 | 41,250.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320000395/0000899243-20-000395-index.htm |
| 2020-03-09 | ERIC BJERKHOLT | Chief Financial Officer | Buy | 1,000.00 | 18.97 | 18,970.00 | 41,967.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320007813/0000899243-20-007813-index.htm |
| 2020-02-28 | ERIC BJERKHOLT | Chief Financial Officer | Buy | 9,375.00 | 42,949.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006852/0000899243-20-006852-index.htm | ||
| 2020-03-12 | ERIC BJERKHOLT | Chief Financial Officer | Buy | 1,000.00 | 15.10 | 15,100.00 | 42,967.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320008140/0000899243-20-008140-index.htm |
| 2020-10-13 | des Produits Nestle S.A. Societe | 10% Share Holder | Buy | 43,435,583.00 | 34.50 | 1,498,527,613.50 | 43,435,583.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320028359/0000899243-20-028359-index.htm |
| 2020-05-10 | ERIC BJERKHOLT | Chief Financial Officer | Buy | 2,420.00 | 45,387.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012859/0000899243-20-012859-index.htm | ||
| 2019-09-17 | PATRICK G ENRIGHT | Director | Buy | 12,500.00 | 22.34 | 279,216.25 | 45,561.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319023912/0000899243-19-023912-index.htm |
| 2019-02-22 | Douglas T. Sheehy | Officer | Buy | 12,500.00 | 45,668.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004866/0000899243-19-004866-index.htm | ||
| 2019-12-26 | Douglas T. Sheehy | Officer | Sell | 10,000.00 | 33.03 | 330,322.00 | 45,668.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319030174/0000899243-19-030174-index.htm |
| 2020-01-16 | Douglas T. Sheehy | Officer | Sell | 400.00 | 37.00 | 14,800.00 | 45,668.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320001533/0000899243-20-001533-index.htm |
| 2020-01-16 | Douglas T. Sheehy | Officer | Buy | 400.00 | 12.95 | 5,180.00 | 46,068.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320001533/0000899243-20-001533-index.htm |
| 2020-05-27 | Mark T Iwicki | Director | Buy | 7,840.00 | 47,407.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014621/0000899243-20-014621-index.htm | ||
| 2018-11-19 | Susan E. Barrowcliffe | General Manager, Europe | Buy | 40,000.00 | 3.02 | 120,880.00 | 49,375.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318029542/0000899243-18-029542-index.htm |
| 2020-10-05 | ERIC BJERKHOLT | Chief Financial Officer | Buy | 5,200.00 | 19.44 | 101,088.00 | 49,841.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320027457/0000899243-20-027457-index.htm |
| 2020-02-07 | des Produits Nestle S.A. Societe | 10% Share Holder | Buy | 525,634.00 | 319.68 | 168,032,048.95 | 525,634.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320011298/0000899243-20-011298-index.htm |
| 2020-03-17 | PATRICK G ENRIGHT | Director | Buy | 8,787.00 | 11.50 | 101,050.50 | 54,348.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320009016/0000899243-20-009016-index.htm |
| 2020-05-10 | Douglas T. Sheehy | Officer | Buy | 2,420.00 | 55,378.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320012855/0000899243-20-012855-index.htm | ||
| 2019-12-26 | Douglas T. Sheehy | Officer | Buy | 10,000.00 | 12.95 | 129,500.00 | 55,668.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319030174/0000899243-19-030174-index.htm |
| 2020-02-28 | Douglas T. Sheehy | Officer | Buy | 11,250.00 | 56,918.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320006843/0000899243-20-006843-index.htm | ||
| 2018-06-19 | Jayson Donald Alexander Dallas | President and CEO | Buy | 60,000.00 | 60,000.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318017243/0000899243-18-017243-index.htm | ||
| 2020-03-17 | PATRICK G ENRIGHT | Director | Buy | 100,000.00 | 11.40 | 1,139,650.00 | 6,113,134.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320009016/0000899243-20-009016-index.htm |
| 2018-11-19 | Jayson Donald Alexander Dallas | President and CEO | Buy | 3,600.00 | 27.56 | 99,208.80 | 63,600.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318029386/0000899243-18-029386-index.htm |
| 2018-11-19 | Jayson Donald Alexander Dallas | President and CEO | Buy | 50.00 | 27.56 | 1,378.00 | 63,650.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318029386/0000899243-18-029386-index.htm |
| 2020-10-02 | DANIEL C MD ADELMAN | Chief Medical Officer | Buy | 34,932.00 | 11.45 | 399,971.40 | 63,807.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320027460/0000899243-20-027460-index.htm |
| 2019-05-23 | KATHRYN E FALBERG | Director | Buy | 6,442.00 | 65,192.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319014969/0000899243-19-014969-index.htm | ||
| 2020-03-18 | PATRICK G ENRIGHT | Director | Buy | 16,213.00 | 11.06 | 179,344.96 | 70,561.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320009016/0000899243-20-009016-index.htm |
| 2020-05-27 | KATHRYN E FALBERG | Director | Buy | 7,840.00 | 73,032.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014615/0000899243-20-014615-index.htm | ||
| 2020-05-27 | PATRICK G ENRIGHT | Director | Sell | 7,840.00 | 78,401.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320014612/0000899243-20-014612-index.htm | ||
| 2018-02-26 | Nestle Health Science US Holdings, Inc. | 10% Share Holder | Buy | 937,500.00 | 32.00 | 30,000,000.00 | 8,489,584.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320011292/0000899243-20-011292-index.htm |
| 2020-10-05 | Douglas T. Sheehy | Officer | Buy | 30,888.00 | 12.95 | 399,999.60 | 85,426.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924320027458/0000899243-20-027458-index.htm |
| 2018-03-04 | Susan E. Barrowcliffe | General Manager, Europe | Buy | 9,375.00 | 9,375.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318006569/0000899243-18-006569-index.htm | ||
| 2018-11-19 | Susan E. Barrowcliffe | General Manager, Europe | Sell | 40,000.00 | 30.04 | 1,201,600.00 | 9,375.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924318029542/0000899243-18-029542-index.htm |
| 2019-02-22 | Jayson Donald Alexander Dallas | President and CEO | Buy | 35,000.00 | 98,650.00 | https://www.sec.gov/Archives/edgar/data/1631650/000089924319004861/0000899243-19-004861-index.htm |